[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100291646":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":7,"responsibleParty":19,"collaborators":21,"id":26,"slug":27,"hasResults":28,"nctId":29,"briefTitle":30,"officialTitle":30,"acronym":7,"eligibilityCriteria":31,"healthyVolunteers":28,"sex":32,"minAge":33,"maxAge":34,"enrollmentInfo":35,"targetDuration":7,"studyType":38,"phases":7,"briefSummary":39,"conditions":40,"keywords":42,"overallStatus":47,"whyStopped":7,"lastUpdateSubmitDate":48,"lastUpdatePostDateStruct":49,"startDateStruct":52,"completionDateStruct":54,"leadSponsor":56,"locationsCount":7},{"fullName":5,"class":6},"RenJi Hospital","OTHER",null,[9],{"name":10,"affiliation":11,"role":12},"JIAN WANG, M.D.","Department of Biliary-pancreatic Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University","PRINCIPAL_INVESTIGATOR",[14],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"Tao Chen, M.D.","CONTACT","+8613601779874","dr_chentao78@163.com",{"type":20,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[22,24],{"name":23,"class":6},"Shanghai Changzheng Hospital",{"name":25,"class":6},"The University of Queensland","100291646","the-role-of-ctdna-pvt1-and-ros-in-diagnosis-and-treatment-of-gastrointestinal-and-hepatobiliary-pancreatic-cancer-100291646",false,"NCT03076502","The Role of ctDNA, PVT1 and ROS in Diagnosis and Treatment of Gastrointestinal and Hepatobiliary Pancreatic Cancer","Inclusion Criteria:\n\n* Patients with suspected of gastrointestinal and hepatobiliary pancreatic cancer\n* Age from 18 - 80 years\n* No serious organic and mental illness;\n\nExclusion Criteria:\n\n* Pregnancy\n* No pathologic result\n* Suffering other malignancies at the same time.","ALL","18 Years","80 Years",{"count":36,"type":37},500,"ESTIMATED","OBSERVATIONAL","This study aims to evaluate the role of ct-DNA, PVT1 and reactive oxygen species (ROS) as biomarkers in the diagnosis, treatment and recurrence monitoring of gastrointestinal and hepatobiliary pancreatic cancer.",[41],"Neoplasms, Gastrointestinal",[43,44,45,46],"ctDNA","Gastrointestinal Cancer","ROS","Hepatobiliary Pancreatic Cancer","UNKNOWN","2017-03-10",{"date":50,"type":51},"2017-03-13","ACTUAL",{"date":53,"type":37},"2017-04",{"date":55,"type":37},"2019-04",{"name":5,"class":6}]